NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
- None.
- None.
Date/Time: |
Tuesday, March 26, 4:30 p.m. ET / 1:30 p.m. PT |
|
|
|
|
Pre-Registration: |
Participants can pre-register for the conference call here: |
|
|
|
|
|
Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. |
|
|
|
|
Dial In: |
Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call: |
|
833-816-1121 from within the |
||
412-317-1862 from outside the |
The live webcast of the conference call also will be available on the Events section of the Company website. A replay of the call will be available beginning two hours after its completion through April 16, 2024 by dialing 877-344-7529 from within the
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare, skincare and wound care products. NovaBay’s leading product Avenova® Antimicrobial Lid & Lash Solution is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to consumers through online distribution channels such as Amazon.com. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne® brand is distributed through commercial partners in the
Socialize and Stay Informed on NovaBay’s Progress
Like us on Facebook
Follow us on X
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website
Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240325019136/en/
NovaBay Contact
Justin Hall
Chief Executive Officer and General Counsel
510-899-8800
jhall@novabay.com
Investor Contact
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com
Source: NovaBay Pharmaceuticals, Inc.
FAQ
When will NovaBay Pharmaceuticals release its financial results for the three and 12 months ending December 31, 2023?
What time will the investor conference call start on March 26, 2024?
How can participants pre-register for the conference call?
What are the dial-in numbers for the live conference call?